News Sofinnova adds a digital medicine string to its VC bow Life sciences venture capital company Sofinnova has launched a new strategy in digital medicine, accompanied by a series of investments in start-ups operating within the c
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face